SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950005-04-000899
Filing Date
2004-12-30
Accepted
2004-12-30 12:45:55
Documents
1
Group Members
ALIX MARDUELALTA BIOPHARMA MANAGEMENT, LLCALTA BIOPHARMA PARTNERS, L.P.ALTA EMBARCADERO BIOPHARMA PARTNERS, L.P.ALTA PARTNERSALTA/CHASE BIOPHARMA MANAGEMENT, LLCDANIEL JANNEYGARRETT GRUENERGUY NOHRAJEAN DELEAGELA JOLLA CHASE PARTNERS (ALTA BIO), LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #4 EXIT FILING p19057_13d.txt SC 13D/A 56959
  Complete submission text file 0000950005-04-000899.txt   59432
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Subject) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-44849 | Film No.: 041233206
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE EMBARCADERO CENTER STE 4050 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER STE 4050 SAN FRANCISCO CA 94111 4153624022
ALTA PARTNERS (Filed by) CIK: 0001060013 (see all company filings)

IRS No.: 943238854 | State of Incorp.: CA | Fiscal Year End: 1231